Related Experiment Video

Updated: Jun 20, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
06:10

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock

Published on: June 12, 2021

Short- and long-term outcomes of percutaneous coronary interventions in patients with severe left ventricular

Imad Sheiban1, Claudio Moretti, Giuseppe Biondi Zoccai

  • 1Interventional Cardiology, Division of Cardiology, University of Torino, San Giovanni Battista Hospital, Torino, Italy.

Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
|September 10, 2009
PubMed

Insights

Percutaneous coronary intervention (PCI) offers excellent procedural success for patients with coronary artery disease and severe left ventricular dysfunction. Long-term outcomes show acceptable morbidity and mortality, making PCI a viable option.

Area of Science:

  • Cardiology
  • Interventional Cardiology

Background:

  • Severe left ventricular dysfunction (EF < 30%) poses high risk for revascularization procedures.
  • Coronary artery disease (CAD) with impaired left ventricular function requires careful treatment strategies.

Purpose of the Study:

  • To assess the immediate and long-term results of percutaneous coronary intervention (PCI) in patients with CAD and severe left ventricular dysfunction.
  • To evaluate the safety and efficacy of PCI in a high-risk patient cohort.

Main Methods:

  • Seventy-eight patients with CAD and EF < 30% underwent PCI.
  • Analysis of procedural success, adverse events, and long-term follow-up outcomes.
  • Identification of independent predictors for mortality and major adverse cardiac events (MACE).

Main Results:

  • High procedural success rate (97.8%) with low in-hospital adverse events (7.8%).
  • At a mean follow-up of 25 months, event-free survival was 55%, with 27.6% requiring repeat revascularization.
  • Female gender, diabetes, myocardial infarction, and treated vessel count predicted adverse outcomes.

Conclusions:

  • PCI is a safe and effective option for symptomatic patients with CAD and severe left ventricular dysfunction.
  • The procedure demonstrates excellent procedural success and acceptable long-term morbidity and mortality.
Abstract

More Related Videos

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...